Nexgel Inc Cash Flow Conversion Efficiency
Nexgel Inc cash flow conversion efficiency. Based on the latest financial reports, Nexgel Inc (NXGL) has a cash flow conversion efficiency ratio of -0.402x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.20 Million) by net assets ($5.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nexgel Inc (2016–2025)
Cash flow conversion efficiency of Nexgel Inc from 2016 to 2025. This chart illustrates how Nexgel Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nexgel Inc (NXGL) share price today for real-time trading data and today's change.
Nexgel Inc Cash Flow Conversion Ratio Explained
Nexgel Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nexgel Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexgel Inc ranked by their cash flow conversion efficiency. Also see market value of Nexgel Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Simbhaoli Sugars Limited
NSE:SIMBHALS
|
-0.186x |
|
Pearl Polymers Limited
NSE:PEARLPOLY
|
-0.121x |
|
Fly-E Group, Inc. Common Stock
NASDAQ:FLYE
|
-0.014x |
|
SKONEC Entertainment Co. Ltd.
KQ:276040
|
-0.163x |
|
Softimat S.A.
BR:SOFT
|
-0.060x |
|
Freedom Care Group Holdings Ltd
AU:FCG
|
-3.256x |
|
Vectus Biosystems Ltd
AU:VBS
|
2.572x |
|
CDT Environmental Technology Investment Holdings Limited ordinary shares
NASDAQ:CDTG
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Nexgel Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Nexgel Inc from 2016 to 2025. Review Nexgel Inc (NXGL) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.89 Million | $-1.31 Million | -0.268x | +57.86% |
| 2024-12-31 | $6.08 Million | $-3.87 Million | -0.636x | -1.54% |
| 2023-12-31 | $5.17 Million | $-3.24 Million | -0.626x | -59.89% |
| 2022-12-31 | $7.64 Million | $-2.99 Million | -0.392x | -71.98% |
| 2021-12-31 | $12.09 Million | $-2.75 Million | -0.228x | +99.10% |
| 2020-12-31 | $71.00K | $-1.80 Million | -25.366x | -431.38% |
| 2019-12-31 | $380.00K | $-1.81 Million | -4.774x | +13.12% |
| 2018-12-31 | $281.00K | $-1.54 Million | -5.495x | -341.98% |
| 2017-12-31 | $625.00K | $-777.00K | -1.243x | +25.05% |
| 2016-12-31 | $794.00K | $-1.32 Million | -1.659x | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more